| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | transcription factor TFIIIB complex | 1.33e-04 | 3 | 140 | 2 | GO:0000126 | |
| GeneOntologyCellularComponent | piccolo histone acetyltransferase complex | 2.65e-04 | 4 | 140 | 2 | GO:0032777 | |
| Domain | Enhancer_polycomb | 5.11e-05 | 2 | 134 | 2 | IPR024943 | |
| Domain | Enhancer_polycomb_C | 5.11e-05 | 2 | 134 | 2 | IPR009607 | |
| Domain | E_Pc_C | 5.11e-05 | 2 | 134 | 2 | PF06752 | |
| Domain | DUF1220 | 5.71e-05 | 11 | 134 | 3 | PF06758 | |
| Domain | NBPF_dom | 5.71e-05 | 11 | 134 | 3 | IPR010630 | |
| Domain | NBPF | 5.71e-05 | 11 | 134 | 3 | PS51316 | |
| Domain | LAM_G_DOMAIN | 1.55e-04 | 38 | 134 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.89e-04 | 40 | 134 | 4 | PF02210 | |
| Domain | LamG | 2.75e-04 | 44 | 134 | 4 | SM00282 | |
| Domain | DUF1908 | 3.04e-04 | 4 | 134 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 3.04e-04 | 4 | 134 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 3.04e-04 | 4 | 134 | 2 | IPR023142 | |
| Domain | - | 3.04e-04 | 4 | 134 | 2 | 1.20.1480.20 | |
| Domain | PHD | 4.52e-04 | 89 | 134 | 5 | SM00249 | |
| Domain | Znf_PHD | 5.01e-04 | 91 | 134 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.10e-04 | 95 | 134 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 6.39e-04 | 96 | 134 | 5 | PS01359 | |
| Domain | Znf_FYVE_PHD | 6.74e-04 | 147 | 134 | 6 | IPR011011 | |
| Domain | PDZ | 7.76e-04 | 151 | 134 | 6 | PS50106 | |
| Domain | Laminin_G | 7.96e-04 | 58 | 134 | 4 | IPR001791 | |
| Domain | PDZ | 8.03e-04 | 152 | 134 | 6 | IPR001478 | |
| Pubmed | CCP110 EPC2 VPS72 DLGAP5 XRCC1 SRBD1 TRIP12 MECP2 LUZP1 NSD3 ESCO2 CCDC66 TBC1D31 ZNF592 RECQL5 EPC1 HADHA PHIP | 1.76e-10 | 645 | 142 | 18 | 25281560 | |
| Pubmed | SOX6 EPC2 RPL27A EDC3 TCF20 ATN1 VPS72 ATXN7L1 SH3KBP1 R3HDM2 ZNF217 XRCC1 MLLT10 ANKHD1 FAT1 ZNF592 DGKK RECQL5 EPC1 MKI67 N4BP1 HADHA MBD2 SNTB1 GABPA | 7.72e-10 | 1429 | 142 | 25 | 35140242 | |
| Pubmed | EPC2 ATN1 VPS72 TCOF1 ATXN7L1 ZNF618 SCEL ANKHD1 MAST2 MECP2 ADCY9 LUZP1 NSD3 MLKL FAT1 TC2N ZNF592 EPC1 MACF1 MBD2 PHIP | 5.86e-09 | 1116 | 142 | 21 | 31753913 | |
| Pubmed | 2.04e-08 | 21 | 142 | 5 | 16079250 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.69e-08 | 170 | 142 | 9 | 23314748 | |
| Pubmed | 1.42e-07 | 199 | 142 | 9 | 23382691 | ||
| Pubmed | MAGI1 EPC2 RPL27A EDC3 VPS72 XRCC1 MAST2 MEAK7 MECP2 NSD3 ARG1 LPIN1 FAT1 PHF3 TMOD1 | 1.64e-07 | 689 | 142 | 15 | 36543142 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 RPL27A TCF20 VPS72 TCOF1 CENPF APTX DLGAP5 XRCC1 SRBD1 PNISR TRIP12 MECP2 NSD3 PHF3 RECQL5 EPC1 MKI67 HADHA MBD2 | 3.36e-07 | 1294 | 142 | 20 | 30804502 |
| Pubmed | 5.21e-07 | 72 | 142 | 6 | 33726789 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TCF20 DLGAP5 XRCC1 SRBD1 TRIP12 MECP2 NSD3 ZNF592 PHF3 RECQL5 MKI67 PHIP GABPA | 1.39e-06 | 608 | 142 | 13 | 36089195 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.61e-06 | 197 | 142 | 8 | 20811636 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 EDC3 CENPF ZNF618 VPS13C PCLO RPS16 AGPS TRIP12 DENND6A ZNF592 HADHA MAPK9 DOP1B | 2.12e-06 | 736 | 142 | 14 | 29676528 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 CCP110 EDC3 TCF20 MAP4 MAST2 ARHGEF16 TRIP12 NARS2 LUZP1 NSD3 PHF3 STARD9 MACF1 DOP1B | 2.64e-06 | 861 | 142 | 15 | 36931259 |
| Pubmed | TCF20 TCOF1 MAP4 CENPF RPS16 ANKHD1 TRIP12 IGF2R PHF3 MKI67 MACF1 HADHA PHIP | 3.05e-06 | 653 | 142 | 13 | 22586326 | |
| Pubmed | EDC3 VPS72 MAP4 APTX NBPF26 ZNF217 XRCC1 SRBD1 ANKHD1 PNISR MECP2 LUZP1 NSD3 JARID2 ZNF592 PHF3 RECQL5 MACF1 MBD2 GABPA | 3.15e-06 | 1497 | 142 | 20 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCF20 ATN1 TCOF1 MAP4 DLGAP5 ZNF217 PNISR TRIP12 MECP2 ZNF551 CCNT2 ZNF592 PHF3 MKI67 | 3.78e-06 | 774 | 142 | 14 | 15302935 |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 4.07e-06 | 58 | 142 | 5 | 37117185 | |
| Pubmed | 4.30e-06 | 103 | 142 | 6 | 32744500 | ||
| Pubmed | Identification of disease-relevant modulators of the SHH pathway in the developing brain. | 5.50e-06 | 9 | 142 | 3 | 34463328 | |
| Pubmed | 5.58e-06 | 233 | 142 | 8 | 37704626 | ||
| Pubmed | BDP1 CCP110 ZFP3 ATXN7L1 SH3KBP1 XRCC1 CPS1 NARS2 TIAM2 LUZP1 EVI5 LPIN1 ADGRG7 FAT1 RECQL5 HSPA14 HYDIN DOP1B | 5.86e-06 | 1293 | 142 | 18 | 15342556 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 5.97e-06 | 109 | 142 | 6 | 33554859 | |
| Pubmed | RPL27A MYO1A CENPF PCLO SRBD1 PNISR TRIP12 MECP2 NARS2 LUZP1 TBC1D31 LATS2 STARD9 DGKK MACF1 HADHA ZNF541 GABPA UTP14C | 6.92e-06 | 1442 | 142 | 19 | 35575683 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 7.83e-06 | 10 | 142 | 3 | 22973535 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | URI1 RPS16 XRCC1 MLLT10 TRIP12 MECP2 NSD3 CCNT2 ZNF592 MKI67 PHIP | 1.30e-05 | 533 | 142 | 11 | 30554943 |
| Pubmed | 1.43e-05 | 12 | 142 | 3 | 27300315 | ||
| Pubmed | RPL27A TCOF1 MAP4 DLGAP5 RPS16 XRCC1 MECP2 ZNF592 MKI67 HADHA | 1.46e-05 | 441 | 142 | 10 | 31239290 | |
| Pubmed | 1.64e-05 | 130 | 142 | 6 | 12421765 | ||
| Pubmed | A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. | 1.66e-05 | 2 | 142 | 2 | 11242117 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15939760 | ||
| Pubmed | XRCC1 phosphorylation affects aprataxin recruitment and DNA deadenylation activity. | 1.66e-05 | 2 | 142 | 2 | 29477978 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24637679 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10806349 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9735366 | ||
| Pubmed | Components of the DNA methylation system of chromatin control are RNA-binding proteins. | 1.66e-05 | 2 | 142 | 2 | 15342650 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26715271 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 14755728 | ||
| Pubmed | Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. | 1.66e-05 | 2 | 142 | 2 | 14633992 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23335972 | ||
| Pubmed | Defective DNA ligation during short-patch single-strand break repair in ataxia oculomotor apraxia 1. | 1.66e-05 | 2 | 142 | 2 | 19103743 | |
| Pubmed | 1.84e-05 | 360 | 142 | 9 | 33111431 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.88e-05 | 361 | 142 | 9 | 26167880 | |
| Pubmed | Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin. | 2.92e-05 | 15 | 142 | 3 | 34721382 | |
| Pubmed | 3.45e-05 | 300 | 142 | 8 | 28561026 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TCF20 VPS72 MAP4 DLGAP5 RPS16 XRCC1 TRIP12 MECP2 LUZP1 NSD3 PHF3 RECQL5 MKI67 PHIP | 3.87e-05 | 954 | 142 | 14 | 36373674 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL27A TCF20 TCOF1 ZNF618 RPS16 TRIM71 AGPS PNISR TRIP12 MECP2 NSD3 ARG1 CCNT2 MACF1 HADHA | 3.88e-05 | 1082 | 142 | 15 | 38697112 |
| Pubmed | EDC3 RASA2 MAP4 DLGAP5 ANKHD1 TRIP12 WDFY4 TIAM2 ESCO2 IGF2R TBC1D31 MACF1 HMGXB3 CPLANE1 UTP14C | 3.96e-05 | 1084 | 142 | 15 | 11544199 | |
| Pubmed | 3.96e-05 | 152 | 142 | 6 | 34299191 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL27A TCF20 RASA2 MAP4 DLGAP5 RPS16 AGPS SRBD1 ANKHD1 TRIP12 LUZP1 ARG1 RECQL5 MKI67 MACF1 HADHA PHIP | 3.97e-05 | 1353 | 142 | 17 | 29467282 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.03e-05 | 398 | 142 | 9 | 35016035 | |
| Pubmed | 4.44e-05 | 503 | 142 | 10 | 16964243 | ||
| Pubmed | TCOF1 MAP4 APTX TRIM71 AGPS ANKHD1 TRIP12 MECP2 LUZP1 ESCO2 PHF3 STARD9 MKI67 TMOD1 HADHA MBD2 HSPA14 | 4.68e-05 | 1371 | 142 | 17 | 36244648 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 11682618 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 33173537 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 29476049 | ||
| Pubmed | PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression. | 4.95e-05 | 3 | 142 | 2 | 37159932 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 16322543 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 36737842 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 20153804 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25798578 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19177165 | ||
| Pubmed | Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. | 4.95e-05 | 3 | 142 | 2 | 10713046 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23663701 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19131340 | ||
| Pubmed | Sex-steroid milieu determines diabetes rescue in pttg-null mice. | 4.95e-05 | 3 | 142 | 2 | 16731783 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 16959877 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23867215 | ||
| Pubmed | Characterization of the pituitary tumor transforming gene 1 knockout mouse retina. | 4.95e-05 | 3 | 142 | 2 | 21203837 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 15380105 | ||
| Pubmed | PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. | 4.95e-05 | 3 | 142 | 2 | 17652795 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28301542 | ||
| Pubmed | Common PTP4A1-PHF3-EYS variants are specific for alcohol dependence. | 4.95e-05 | 3 | 142 | 2 | 24961364 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24395789 | ||
| Pubmed | Association of rare PTP4A1-PHF3-EYS variants with alcohol dependence. | 4.95e-05 | 3 | 142 | 2 | 23324950 | |
| Pubmed | The lifespan quantitative trait locus gene Securin controls hematopoietic progenitor cell function. | 4.95e-05 | 3 | 142 | 2 | 31073078 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 34262048 | ||
| Pubmed | Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis. | 4.95e-05 | 3 | 142 | 2 | 25936962 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 12646234 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 17626243 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 15281346 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 20398247 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18639540 | ||
| Pubmed | The FHA domain of aprataxin interacts with the C-terminal region of XRCC1. | 4.95e-05 | 3 | 142 | 2 | 15555565 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 12626748 | ||
| Pubmed | The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. | 4.95e-05 | 3 | 142 | 2 | 16964241 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28516917 | ||
| Pubmed | Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter. | 4.95e-05 | 3 | 142 | 2 | 10650958 | |
| Pubmed | Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells. | 4.95e-05 | 3 | 142 | 2 | 24166297 | |
| Pubmed | Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise. | 4.95e-05 | 3 | 142 | 2 | 27923996 | |
| Pubmed | Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. | 4.95e-05 | 3 | 142 | 2 | 17065388 | |
| Pubmed | The cell-intrinsic requirement of Sox6 for cortical interneuron development. | 5.20e-05 | 18 | 142 | 3 | 19709629 | |
| Pubmed | NBPF8 RPL27A MAP4 RPS16 NBPF11 STARD9 NBPF9 NBPF10 NBPF14 DYRK3 | 5.23e-05 | 513 | 142 | 10 | 25798074 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL27A TCF20 TCOF1 CENPF DLGAP5 RPS16 ZNF217 SRBD1 TRIP12 ZNF592 PHF3 MKI67 HADHA MBD2 | 5.69e-05 | 989 | 142 | 14 | 36424410 |
| Pubmed | 6.15e-05 | 19 | 142 | 3 | 15647280 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL27A MAP4 CENPF RPS16 XRCC1 SRBD1 TRIP12 PHF3 MKI67 TMOD1 MACF1 HSPA14 | 7.02e-05 | 759 | 142 | 12 | 35915203 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL27A TCF20 TCOF1 MAP4 CENPF XRCC1 AGPS TRIP12 ARG1 IGF2R MKI67 MACF1 HADHA PHIP | 8.23e-05 | 1024 | 142 | 14 | 24711643 |
| Pubmed | The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. | 8.40e-05 | 21 | 142 | 3 | 27088858 | |
| Pubmed | RPL27A EDC3 TCOF1 VPS13C RPS16 AGPS TRIP12 ADCY9 FAT1 DENND6A IGF2R MKI67 | 8.76e-05 | 777 | 142 | 12 | 35844135 | |
| Pubmed | 9.21e-05 | 177 | 142 | 6 | 26206133 | ||
| Pubmed | 9.62e-05 | 446 | 142 | 9 | 24255178 | ||
| Interaction | H2BC21 interactions | EPC2 TCF20 VPS72 CENPF ATXN7L1 PCLO APTX XRCC1 MLLT10 SRBD1 TRIP12 MECP2 NSD3 LATS2 PHF3 MKI67 ZNF518B PHIP | 1.47e-06 | 696 | 139 | 18 | int:H2BC21 |
| Interaction | H2BC8 interactions | EPC2 TCF20 VPS72 DLGAP5 XRCC1 SRBD1 TRIP12 MECP2 NSD3 ESCO2 ZNF592 PHF3 RECQL5 MKI67 PHIP | 1.08e-05 | 576 | 139 | 15 | int:H2BC8 |
| Interaction | TMEM132D interactions | 1.22e-05 | 74 | 139 | 6 | int:TMEM132D | |
| Cytoband | 1q21.1 | 1.48e-06 | 62 | 142 | 5 | 1q21.1 | |
| Cytoband | 1q41 | 5.45e-05 | 66 | 142 | 4 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 2.07e-04 | 93 | 142 | 4 | chr1q41 | |
| GeneFamily | Neuroblastoma breakpoint family | 8.55e-10 | 23 | 85 | 6 | 662 | |
| GeneFamily | PDZ domain containing | 8.10e-05 | 152 | 85 | 6 | 1220 | |
| GeneFamily | PHD finger proteins | 8.55e-04 | 90 | 85 | 4 | 88 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.17e-03 | 11 | 85 | 2 | 1025 | |
| GeneFamily | Immunoglobulin like domain containing | 2.16e-03 | 193 | 85 | 5 | 594 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TPST1 URI1 CENPF DLGAP5 R3HDM2 MAST2 PNISR TRIP12 MECP2 ADCY9 EVI5 JARID2 FAT1 IGF2R TBC1D31 PHF3 MACF1 N4BP1 MBD2 IL1RAP NBPF14 PHIP DOP1B | 2.35e-10 | 856 | 142 | 23 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CENPF ZNF217 PNISR MECP2 ADCY9 JARID2 FAT1 PHF3 MKI67 N4BP1 MBD2 PHIP | 9.39e-08 | 300 | 142 | 12 | M8702 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 RPL27A URI1 RASA2 VPS13C SH3KBP1 RPS16 ZNF217 PNISR TRIP12 MECP2 LUZP1 LPIN1 JARID2 CCNT2 TC2N PHF3 EPC1 MACF1 N4BP1 MBD2 PHIP LDLRAD4 GABPA MAST3 | 4.34e-07 | 1492 | 142 | 25 | M40023 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.30e-06 | 145 | 142 | 8 | M1810 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CENPF R3HDM2 PNISR TRIP12 MECP2 EVI5 JARID2 FAT1 PHF3 MBD2 IL1RAP PHIP DOP1B | 1.63e-06 | 466 | 142 | 13 | M13522 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | NBPF8 URI1 CENPF VPS13C VPS8 ARHGEF16 WDFY4 MECP2 TIAM2 LUZP1 ADGB ADGRG7 SV2B NBPF10 DCLK3 HMGXB3 | 2.17e-05 | 873 | 142 | 16 | M16009 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 6.53e-05 | 481 | 142 | 11 | M3898 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 7.94e-05 | 189 | 142 | 7 | M3112 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | SH3KBP1 ZNF217 AGPS NSD3 EVI5 JARID2 DENND6A LATS2 ULK4 MACF1 LDLRAD4 | 8.89e-05 | 498 | 142 | 11 | M1741 |
| Coexpression | GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN | 9.97e-05 | 196 | 142 | 7 | M4431 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 1.03e-04 | 197 | 142 | 7 | M4421 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | SH3KBP1 ZNF217 AGPS NSD3 EVI5 JARID2 DENND6A LATS2 ULK4 MACF1 LDLRAD4 | 1.04e-04 | 507 | 142 | 11 | MM1030 |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP | 1.06e-04 | 198 | 142 | 7 | M5580 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 1.13e-04 | 200 | 142 | 7 | M5282 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 MAGI1 TPST1 TCF20 ATN1 MAP4 CENPF SH3KBP1 R3HDM2 CPD ANKHD1 MAST2 MECP2 LUZP1 EVI5 CCDC66 EPC1 MKI67 MACF1 N4BP1 CPLANE1 PHIP UTP14C | 1.41e-09 | 780 | 139 | 23 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX6 BDP1 MAGI1 TCF20 ATN1 CENPF PCLO SH3KBP1 MDGA2 R3HDM2 NCKAP5 CPD ANKHD1 MAST2 PNISR MECP2 LUZP1 CCDC66 EPC1 MKI67 PHIP | 1.11e-07 | 831 | 139 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.61e-07 | 192 | 139 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 CENPF LUZP1 EVI5 CCDC66 MKI67 MACF1 N4BP1 CPLANE1 PHIP UTP14C | 3.51e-06 | 291 | 139 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | BDP1 RPL27A CENPF PCLO LUZP1 CCDC66 MKI67 TMOD1 MACF1 N4BP1 MERTK PHIP UTP14C | 2.17e-05 | 492 | 139 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX6 BDP1 CCP110 EPC2 URI1 TCOF1 CENPF ZNF618 PNISR LUZP1 ESCO2 EVI5 JARID2 CCDC66 PHF3 CNTNAP2 MKI67 MACF1 ZNF518B CPLANE1 PHIP DYRK3 | 2.25e-05 | 1257 | 139 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 EPC2 URI1 CENPF DLGAP5 MDGA2 PNISR LUZP1 CCDC66 TBC1D31 MKI67 MACF1 N4BP1 PHIP | 6.75e-05 | 629 | 139 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | BDP1 EPC2 RPL27A MDGA2 LUZP1 CCDC66 DGKK MKI67 TMOD1 MACF1 MERTK LDLRAD4 | 9.75e-05 | 492 | 139 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.48e-04 | 232 | 139 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.56e-04 | 298 | 139 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX6 BDP1 CCP110 EPC2 URI1 TCOF1 CENPF ZNF618 PNISR LUZP1 ESCO2 EVI5 JARID2 CCDC66 PHF3 CNTNAP2 MKI67 MACF1 ZNF518B CPLANE1 PHIP DYRK3 | 2.01e-04 | 1459 | 139 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.14e-04 | 311 | 139 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.28e-04 | 186 | 139 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX6 MAGI1 CCP110 EPC2 ZFP3 CENPF MLLT10 ESCO2 JARID2 FAT1 CCDC66 PHF3 TGFBRAP1 DGKK CNTNAP2 MKI67 ZNF518B EML1 CPLANE1 PHIP DYRK3 | 2.29e-04 | 1370 | 139 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 RPL27A CENPF PCLO MECP2 LUZP1 EVI5 CCDC66 IGF2R MKI67 TMOD1 MACF1 N4BP1 MERTK CPLANE1 PHIP UTP14C | 2.47e-04 | 985 | 139 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 EPC2 URI1 TCOF1 CENPF PCLO TRIM71 XRCC1 LUZP1 CCDC66 TBC1D31 MKI67 TMOD1 MACF1 N4BP1 PHIP SNTB1 | 2.59e-04 | 989 | 139 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.24e-07 | 139 | 142 | 7 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 179 | 142 | 7 | f3f9c7e575bc4d9d3bce649b90254182e8f6aaec | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 179 | 142 | 7 | 01e0b49e7f03ac9c3e6c34708ead300d27236b8b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 184 | 142 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 187 | 142 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-06 | 190 | 142 | 7 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-06 | 190 | 142 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 193 | 142 | 7 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 2.92e-06 | 193 | 142 | 7 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 3.02e-06 | 194 | 142 | 7 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.58e-06 | 199 | 142 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-06 | 199 | 142 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 3.70e-06 | 200 | 142 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.70e-06 | 200 | 142 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-06 | 148 | 142 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 155 | 142 | 6 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 155 | 142 | 6 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.22e-05 | 159 | 142 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.22e-05 | 159 | 142 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 163 | 142 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 168 | 142 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-05 | 170 | 142 | 6 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-05 | 171 | 142 | 6 | 943fbca8a6ac04052a2a85aca7b21a3461cd96f7 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 171 | 142 | 6 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 171 | 142 | 6 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 172 | 142 | 6 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 172 | 142 | 6 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 174 | 142 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 174 | 142 | 6 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-05 | 175 | 142 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 177 | 142 | 6 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 183 | 142 | 6 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 183 | 142 | 6 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.78e-05 | 184 | 142 | 6 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.87e-05 | 185 | 142 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.96e-05 | 186 | 142 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-Cycling_NK|GI_small-bowel / Manually curated celltypes from each tissue | 3.05e-05 | 187 | 142 | 6 | 265c690c2921fd201361a0ec8bc4d2a996fbcaf4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.14e-05 | 188 | 142 | 6 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-05 | 189 | 142 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 3.33e-05 | 190 | 142 | 6 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 190 | 142 | 6 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 191 | 142 | 6 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.53e-05 | 192 | 142 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.53e-05 | 192 | 142 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 3.64e-05 | 193 | 142 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.64e-05 | 193 | 142 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-05 | 117 | 142 | 5 | 5a23770806b4612bed4ae6fd716abdec7f7f56c6 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-05 | 194 | 142 | 6 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 3.74e-05 | 194 | 142 | 6 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.74e-05 | 194 | 142 | 6 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 3.74e-05 | 194 | 142 | 6 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 195 | 142 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 3.85e-05 | 195 | 142 | 6 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | 15-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 3.96e-05 | 196 | 142 | 6 | 511bfc06c34d5add2ae561cca463d1e4e2d43e20 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.96e-05 | 196 | 142 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 15-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 3.96e-05 | 196 | 142 | 6 | bf2670e5ae996a19987bc70aa5a37d133db789eb | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.08e-05 | 197 | 142 | 6 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | 21-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.08e-05 | 197 | 142 | 6 | 9f8eb6305ade0654bbcd8f19963be0b64af083de | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 4.08e-05 | 197 | 142 | 6 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | 21-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 4.08e-05 | 197 | 142 | 6 | 4710b55806a618076a954190f519e49c55d300d3 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.19e-05 | 198 | 142 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 198 | 142 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 198 | 142 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 198 | 142 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 198 | 142 | 6 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-05 | 198 | 142 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 4.31e-05 | 199 | 142 | 6 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.31e-05 | 199 | 142 | 6 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.31e-05 | 199 | 142 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.43e-05 | 200 | 142 | 6 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.43e-05 | 200 | 142 | 6 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 4.43e-05 | 200 | 142 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 4.43e-05 | 200 | 142 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.43e-05 | 200 | 142 | 6 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.65e-05 | 128 | 142 | 5 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.87e-05 | 129 | 142 | 5 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 139 | 142 | 5 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-05 | 139 | 142 | 5 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-05 | 139 | 142 | 5 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 8.94e-05 | 141 | 142 | 5 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.55e-05 | 143 | 142 | 5 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-05 | 75 | 142 | 4 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 144 | 142 | 5 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.87e-05 | 144 | 142 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| Drug | Pesticides | NBPF8 RPS16 XRCC1 NBPF11 NSD3 IGF2R NBPF9 DGKK NBPF10 IL1RAP NBPF14 | 2.30e-09 | 150 | 140 | 11 | ctd:D010575 |
| Drug | PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A | 4.24e-07 | 198 | 140 | 10 | 7076_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Up 200; 10uM; HL60; HG-U133A | 4.06e-06 | 199 | 140 | 9 | 1568_UP | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.26e-05 | 174 | 140 | 8 | 1873_UP | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.28e-05 | 189 | 140 | 8 | 4672_UP | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 2.28e-05 | 189 | 140 | 8 | 2041_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.75e-05 | 194 | 140 | 8 | 4249_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.85e-05 | 195 | 140 | 8 | 5325_UP | |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.85e-05 | 195 | 140 | 8 | 6135_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.96e-05 | 196 | 140 | 8 | 7411_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 6012_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 7148_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.07e-05 | 197 | 140 | 8 | 2328_UP | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.30e-05 | 199 | 140 | 8 | 7445_UP | |
| Disease | serum IgG glycosylation measurement | MAGI1 REC114 VPS13C APTX MDGA2 DNM1P46 EYS SLC8A3 GPR158 CNTNAP2 USH2A SNTB1 | 5.45e-06 | 523 | 135 | 12 | EFO_0005193 |
| Disease | gout | 3.46e-05 | 196 | 135 | 7 | EFO_0004274 | |
| Disease | liver fat measurement | 4.50e-05 | 43 | 135 | 4 | EFO_0010821 | |
| Disease | cholesteryl ester 17:0 measurement | 6.21e-05 | 3 | 135 | 2 | EFO_0021436 | |
| Disease | Tourette syndrome, schizophrenia | 7.27e-05 | 18 | 135 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.14e-04 | 103 | 135 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.53e-04 | 27 | 135 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.57e-04 | 67 | 135 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Disorder of the urea cycle metabolism | 3.08e-04 | 6 | 135 | 2 | cv:C0154246 | |
| Disease | Liver carcinoma | 5.62e-04 | 507 | 135 | 9 | C2239176 | |
| Disease | Alzheimer disease, survival time | 5.71e-04 | 8 | 135 | 2 | EFO_0000714, MONDO_0004975 | |
| Disease | argininate measurement | 5.71e-04 | 8 | 135 | 2 | EFO_0800055 | |
| Disease | Autism Spectrum Disorders | 6.37e-04 | 85 | 135 | 4 | C1510586 | |
| Disease | nasopharyngeal neoplasm | 6.67e-04 | 151 | 135 | 5 | EFO_0004252 | |
| Disease | complement factor D measurement | 8.93e-04 | 93 | 135 | 4 | EFO_0020283 | |
| Disease | tauopathy (implicated_via_orthology) | 9.13e-04 | 10 | 135 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | SOX6 BDP1 MAGI1 R3HDM2 MLLT10 CD163 LPIN1 CNTNAP2 HMGXB3 MERTK PHIP MTARC1 | 9.39e-04 | 904 | 135 | 12 | EFO_0004736 |
| Disease | autistic disorder (is_implicated_in) | 9.44e-04 | 42 | 135 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | sexual dysfunction | 1.11e-03 | 11 | 135 | 2 | EFO_0004714 | |
| Disease | total blood protein measurement | 1.11e-03 | 449 | 135 | 8 | EFO_0004536 | |
| Disease | phenylacetylglutamine measurement | 1.33e-03 | 12 | 135 | 2 | EFO_0021013 | |
| Disease | serum non-albumin protein measurement | 1.41e-03 | 361 | 135 | 7 | EFO_0004568 | |
| Disease | mental or behavioural disorder | 1.43e-03 | 179 | 135 | 5 | EFO_0000677 | |
| Disease | Colorectal Carcinoma | DNAH3 TCOF1 ZNF217 XRCC1 ADAMTSL3 LPIN1 FAT1 BRF1 MKI67 PHIP | 1.50e-03 | 702 | 135 | 10 | C0009402 |
| Disease | IGFBP-1 measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0005118 | |
| Disease | cirrhosis of liver | 1.57e-03 | 13 | 135 | 2 | EFO_0001422 | |
| Disease | visceral adipose tissue measurement | 1.72e-03 | 481 | 135 | 8 | EFO_0004765 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.76e-03 | 52 | 135 | 3 | C1168401 | |
| Disease | physical activity measurement, body mass index | 1.90e-03 | 114 | 135 | 4 | EFO_0004340, EFO_0008002 | |
| Disease | body weight | RASA2 VPS13C MDGA2 MLLT10 CPS1 ADAMTSL3 TRIP12 ADCY9 EYS TBC1D31 PHF3 DGKK ULK4 LDLRAD4 | 1.96e-03 | 1261 | 135 | 14 | EFO_0004338 |
| Disease | Down syndrome (implicated_via_orthology) | 2.10e-03 | 15 | 135 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.10e-03 | 15 | 135 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.35e-03 | 121 | 135 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | colorectal cancer (is_implicated_in) | 2.35e-03 | 121 | 135 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | cranial vault morphology measurement | 2.35e-03 | 121 | 135 | 4 | EFO_0009278 | |
| Disease | body surface area | 2.88e-03 | 643 | 135 | 9 | EFO_0022196 | |
| Disease | Disorder of eye | 2.98e-03 | 212 | 135 | 5 | C0015397 | |
| Disease | comparative body size at age 10, self-reported | 3.28e-03 | 420 | 135 | 7 | EFO_0009819 | |
| Disease | Seizures | 3.35e-03 | 218 | 135 | 5 | C0036572 | |
| Disease | Congenital hernia of foramen of Morgagni | 3.38e-03 | 19 | 135 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.38e-03 | 19 | 135 | 2 | C0265700 | |
| Disease | hydrocephalus (implicated_via_orthology) | 3.38e-03 | 19 | 135 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | serum homoarginine measurement | 3.74e-03 | 20 | 135 | 2 | EFO_0005421 | |
| Disease | Congenital diaphragmatic hernia | 4.12e-03 | 21 | 135 | 2 | C0235833 | |
| Disease | cigarettes per day measurement | 4.12e-03 | 438 | 135 | 7 | EFO_0006525 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.39e-03 | 144 | 135 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | colorectal carcinoma (is_implicated_in) | 4.52e-03 | 22 | 135 | 2 | DOID:0080199 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKVERSTDQVIKPVN | 281 | O60507 | |
| IPSVKQEKRDGSSTN | 191 | Q9H2F5 | |
| RKPGQTVNNKRVSAA | 546 | Q52LR7 | |
| VKENATPTRNTISKV | 2076 | A6H8Y1 | |
| QAARKPKVDGQVSET | 261 | O60583 | |
| IQKSPKGRAVSAIQD | 1211 | Q8N7X0 | |
| RNVSVETRNVKPQGK | 16 | Q6ZS02 | |
| EASTPKVNKQGRSEE | 61 | P54259 | |
| PEGTQKVDATIVVKS | 241 | Q5VV41 | |
| KVKQVGVNPTSIDSV | 71 | Q7Z2E3 | |
| IRGTVSPQKQSAQKV | 1221 | A6QL64 | |
| NTSRNASPEAKKVAI | 191 | Q96K78 | |
| AAQQLTPKEATRTKV | 36 | Q96F81 | |
| ASNPRTSLVQVKTKA | 136 | Q9ULK2 | |
| IVKNPRSVGKASEQL | 66 | P05089 | |
| GKAVIINKTSNTRIP | 221 | Q9Y2K5 | |
| TESQGKDSAKSVPRQ | 166 | Q7Z4M0 | |
| TVSLVGPSRNDQKKT | 196 | Q15283 | |
| RPVSRVTNGTSNKKS | 276 | Q9UPP5 | |
| KAVKTVRTPGAAANL | 441 | P04217 | |
| PGKVNITVVAESKQS | 721 | Q6IE37 | |
| KAVDNGRPQKSSTTR | 1326 | Q14517 | |
| RSKNGVVKDQPSDAA | 366 | P45984 | |
| EERKPKSGQSVQSFI | 1231 | Q5KSL6 | |
| QERTVPDKVQGVSVS | 726 | P23467 | |
| IVKNKTEPVINGTSV | 256 | Q96PR1 | |
| INRTVGQTVKSPDKL | 51 | Q9H079 | |
| IENSPFKVVVKSGRS | 571 | Q2Q1W2 | |
| TDKQSLKQAVGRITP | 141 | O15232 | |
| GTQETRNTTKPKQES | 1121 | Q96QZ7 | |
| NTSAPDLKNVRSKVG | 926 | P27816 | |
| KVKATNFRPNIVISG | 231 | Q5VT66 | |
| PGEAKFKSINTTVRV | 1951 | Q5T1H1 | |
| TVSKGVQINIKAIPS | 271 | Q12866 | |
| NEQIVRVIKQTSPGK | 146 | Q9NRM7 | |
| RFKENSVAVKVVQGP | 1006 | Q9UBC5 | |
| QTAGVEERTKSQKPL | 921 | Q5T848 | |
| TRTLTVKVVGSPKNA | 226 | Q9NPH3 | |
| VINSSAKAAKVQRAP | 286 | Q06546 | |
| NKVNRTKVSVPDANG | 2121 | Q9Y3R5 | |
| TVKRQKQVSPSSEGH | 621 | Q9C098 | |
| ETKAEKVGNQTSVIP | 36 | Q8N2X6 | |
| VSSKGSVVKRNQQPV | 361 | Q12766 | |
| PQTKQADIVRGESVK | 281 | Q9Y6V0 | |
| RNPSGKQVATDKVAE | 11 | O60447 | |
| SPVNAVLGTKTKAAV | 1831 | Q5H8C1 | |
| LVSKSTERTGQKNPE | 256 | Q14693 | |
| VVQTANKTDSPSRKR | 371 | Q14693 | |
| NIPKRTDVKSQDVAV | 116 | Q96F86 | |
| QKLDPAASVTGSKRQ | 2166 | P46013 | |
| ATEGPVKAREVQKFT | 116 | Q6P9B6 | |
| QDQGKRSVPSEKLTT | 46 | Q8NB16 | |
| VGNPAKKSTNIIVRA | 316 | Q7Z553 | |
| VTEKKLANSEPVGTQ | 5471 | Q9UPN3 | |
| ASNVKTILPSKAVGV | 136 | Q86Y26 | |
| RQTASIFKQPVTKVT | 246 | Q9UBB5 | |
| TGQEESKANIESKRP | 766 | Q9UKF2 | |
| PTQTISQGAIEKVKD | 1211 | P31327 | |
| GESVRPKKINNITVS | 5066 | Q4G0P3 | |
| QKVKVAQRSPVDSGT | 3046 | P49454 | |
| AVRKATQSPVTFQKG | 3066 | Q9H799 | |
| QTAARTQGEKVEVTP | 2531 | Q8TD57 | |
| SQADNTSKKVTVRPG | 71 | Q9Y6R7 | |
| PVTKNVTVKSEGAIQ | 851 | O75976 | |
| TRNTVNTSLVGKQKP | 121 | A2RUB6 | |
| RLGTPKSVNKAVSQS | 636 | Q15398 | |
| KGVQQKRPSEAQSVI | 421 | Q8IWF6 | |
| SSGDSNSVRVKINPK | 21 | O60503 | |
| QGTPKTSVKGVVQNR | 966 | O43303 | |
| TSVKGVVQNRQKPSQ | 971 | O43303 | |
| QSEGKKSREQPSVLS | 461 | Q86V48 | |
| NEPSLGRTQKSKSEV | 226 | Q56NI9 | |
| ARPVNKVIKSASATA | 1041 | Q6P0Q8 | |
| ALENTSIKVGPARKN | 1036 | O60307 | |
| KGDVAVVRINSPNSK | 46 | P40939 | |
| AVRTNSPLQVKTGEK | 481 | Q9UHC6 | |
| GVRKETAVPATKSNI | 116 | O00423 | |
| NGPQKKSVDRSIQTV | 241 | Q92904 | |
| ISVQKTPQKATTGRS | 1031 | Q86VB7 | |
| TTIDKVSGKRVVNPA | 531 | O43781 | |
| KVKQILGRSSSDPQA | 66 | Q0VDF9 | |
| NGSSRSTREKEPVQK | 226 | Q92833 | |
| TRVNAAKNKTGAAPI | 86 | P46776 | |
| TTRPKAATSEGVQVK | 196 | P51608 | |
| SKVVSSCQEKREPQG | 1276 | P11717 | |
| GTVNVFVKTQGSRKA | 2331 | O75445 | |
| QVPESISNQKRGVKV | 101 | Q13884 | |
| VEPKRVRINTGKNTT | 341 | O94763 | |
| TSGRVQQPAKSRESK | 371 | Q96DN5 | |
| RAKGTPEKVFTVSNI | 326 | Q7L1I2 | |
| IQTQTPRKKTIGECS | 311 | Q8N9U0 | |
| KVVTAAAQAKQRSPS | 811 | Q13428 | |
| VISSNPATTEVQRKK | 981 | O14513 | |
| QVEVAEKVQKSSSPR | 411 | Q3BBV2 | |
| QIEVAEKVQKSSAPR | 446 | P0DPF3 | |
| QVEVAEKVQKSSAPR | 446 | Q6P3W6 | |
| QVEVAEKVQKSSSPR | 446 | Q86T75 | |
| QVEVAEKVQKSSAPR | 106 | Q5TI25 | |
| QVEVAEKVQKSSAPR | 106 | B4DH59 | |
| SVEVQGQLIKSPSKR | 91 | Q96I59 | |
| VVEVPNSKDQRVKSA | 156 | Q6ZW05 | |
| ANGTVATAAIQPKKV | 196 | Q96B97 | |
| TVNRATEKSVKTNGP | 66 | Q9NZH4 | |
| PLQSVQVFGRKKTAT | 6 | P62249 | |
| TVNRATEKSVKTNGP | 66 | Q9NZH5 | |
| NSSEIKKGRITPSQV | 1321 | Q8N3P4 | |
| VSSLNKVSSQPEKRV | 2476 | Q9P2P6 | |
| TVDIANNSTLGKPKR | 196 | Q9H930 | |
| RVKKNAPQISDGSEV | 66 | Q8N5C6 | |
| SRTQEPSLGKQKVFI | 91 | O75908 | |
| TGIKNEKRGTSPVTQ | 401 | P35712 | |
| QKVARLSDKTGPVAQ | 1051 | P55197 | |
| AAQESGTIPKKRQEV | 76 | O00116 | |
| NVFGKKRANVVTTPS | 1526 | Q8IWZ3 | |
| QVKARIPEVGAVTKQ | 136 | O75829 | |
| QKTSPGRSVKEEAQN | 951 | O94762 | |
| AVQVVPTGNAATVRK | 121 | P0C7Q5 | |
| QKSEEVGVQVFTKRP | 551 | Q8WUH2 | |
| SRKQKASSEGTVPQV | 471 | Q5TAP6 | |
| QTNQSGKKAPASVVR | 316 | Q5T7W0 | |
| RQTVKQGSPTKDIEI | 1576 | Q8IVF5 | |
| RKPKVEVNTNSGEII | 1641 | Q8WWQ0 | |
| VKKFSIVGTRSNDPV | 226 | P28289 | |
| VTPEVKRSNQGSKDL | 396 | O95171 | |
| LQAKRVASVTKEDQP | 291 | Q92610 | |
| SIQVRTSKGNTPTQK | 86 | Q7Z340 | |
| ESLRTKQGPVVDVQK | 786 | Q6ZS81 | |
| VSTAKAGVKQPERSQ | 166 | Q92576 | |
| AKETQILPRQTATGK | 2076 | Q709C8 | |
| NPKVNEKTVGVIVSR | 596 | Q9UGU0 | |
| VSTQPAKKVATGEAL | 596 | Q92994 | |
| KEQVETVPQATVKTG | 601 | Q9BZ95 | |
| PSQKVTVTKLGQFRV | 161 | P18887 | |
| KGTAVVPFRATQEKN | 41 | O75362 | |
| GDVVNEKKRTPNETT | 476 | Q8TF01 | |
| VNTPAGSSQKAREEK | 101 | Q15906 | |
| RANTSERQKTGQVPK | 51 | Q14669 | |
| AQIKKSVSDVPRGQE | 321 | Q5SRN2 | |
| SVSDVPRGQESQVKK | 326 | Q5SRN2 | |
| PRRQESQVKKSQSGV | 376 | Q5SRN2 | |
| LKGPESQVKNTEVSV | 451 | Q5SRN2 | |
| ANVSGRKHPSTVQVK | 826 | Q96C45 | |
| KQAPAENGAASRITK | 716 | Q9H0D2 | |
| LESNKTQRSSVGEKP | 126 | Q96NJ6 | |
| TSKVNIPVKVVSSNR | 556 | Q9C0D4 | |
| KRTKANGTVQVVSPR | 1511 | P82987 | |
| NNAESTIVPIKGKDR | 286 | O15165 | |
| TSQEREVTIKKPNGE | 106 | P57103 | |
| ARNKAGTPVSELTKQ | 236 | O75113 |